WO2000010592A3 - Medicaments permettant de prevenir ou de reduire la cicatrisation - Google Patents

Medicaments permettant de prevenir ou de reduire la cicatrisation Download PDF

Info

Publication number
WO2000010592A3
WO2000010592A3 PCT/GB1999/002634 GB9902634W WO0010592A3 WO 2000010592 A3 WO2000010592 A3 WO 2000010592A3 GB 9902634 W GB9902634 W GB 9902634W WO 0010592 A3 WO0010592 A3 WO 0010592A3
Authority
WO
WIPO (PCT)
Prior art keywords
medicaments
preventing
reducing scarring
scarring
immunomodulator
Prior art date
Application number
PCT/GB1999/002634
Other languages
English (en)
Other versions
WO2000010592A2 (fr
Inventor
Mark William James Ferguson
Salah Chettibi
Original Assignee
Univ Manchester
Mark William James Ferguson
Salah Chettibi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manchester, Mark William James Ferguson, Salah Chettibi filed Critical Univ Manchester
Priority to AU11686/00A priority Critical patent/AU1168600A/en
Publication of WO2000010592A2 publication Critical patent/WO2000010592A2/fr
Publication of WO2000010592A3 publication Critical patent/WO2000010592A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Abstract

L'invention concerne des médicaments utilisés pour prévenir et réduire la cicatrisation, comprenant une quantité thérapeutiquement efficace d'un immunomodulateur. Ces médicaments sont utiles, notamment pour prévenir ou réduire la cicatrisation dermique. L'immunomodulateur peut être une cyclosporine A, FK-506 ou un guanylhydrazone.
PCT/GB1999/002634 1998-08-22 1999-08-23 Medicaments permettant de prevenir ou de reduire la cicatrisation WO2000010592A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU11686/00A AU1168600A (en) 1998-08-22 1999-08-23 Medicaments for preventing or reducing scarring

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9818278.5 1998-08-22
GBGB9818278.5A GB9818278D0 (en) 1998-08-22 1998-08-22 Compositions

Publications (2)

Publication Number Publication Date
WO2000010592A2 WO2000010592A2 (fr) 2000-03-02
WO2000010592A3 true WO2000010592A3 (fr) 2000-06-08

Family

ID=10837638

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/002634 WO2000010592A2 (fr) 1998-08-22 1999-08-23 Medicaments permettant de prevenir ou de reduire la cicatrisation

Country Status (3)

Country Link
AU (1) AU1168600A (fr)
GB (1) GB9818278D0 (fr)
WO (1) WO2000010592A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2326317A1 (fr) * 2008-09-19 2011-06-01 Cytokine Pharmasciences, Inc Guanylhydrazones pour traiter une inflammation intestinale post-opératoire

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001772A1 (fr) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Composition de cyclosporine oculaire
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
WO1992008474A2 (fr) * 1990-11-20 1992-05-29 The National Heart & Lung Institute Traitement des maladies pulmonaires
WO1998013024A2 (fr) * 1996-09-27 1998-04-02 Hyal Pharmaceutical Corporation Systeme hyaluronique d'administration de medicaments
WO1998036061A2 (fr) * 1997-02-13 1998-08-20 The Victoria University Of Manchester Reduction de la fibrose et/ou de la cicatrisation par inhibition de l'activite induite par le recepteur de l'interleukine 6

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001772A1 (fr) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Composition de cyclosporine oculaire
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
WO1992008474A2 (fr) * 1990-11-20 1992-05-29 The National Heart & Lung Institute Traitement des maladies pulmonaires
WO1998013024A2 (fr) * 1996-09-27 1998-04-02 Hyal Pharmaceutical Corporation Systeme hyaluronique d'administration de medicaments
WO1998036061A2 (fr) * 1997-02-13 1998-08-20 The Victoria University Of Manchester Reduction de la fibrose et/ou de la cicatrisation par inhibition de l'activite induite par le recepteur de l'interleukine 6

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BJORK L ET AL: "Targeted suppression of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone ( CNI - 1493 ).", JOURNAL OF INFECTIOUS DISEASES, (1997 NOV) 176 (5) 1303-12., XP000877272 *
DUNCAN J I ET AL: "TOPICAL CYCLOSPORIN AND T LYMPHOCYTES IN KELOID SCARS.", BR. J. DERMATOL., (1991) 124 (1), 109., XP000877267 *
HUNNINGHAKE G.W. ET AL: "Approaches to the treatment of pulmonary fibrosis.", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, (1995) 151/3 I (915-918)., XP000877253 *
SAKAMOTO H ET AL: "Immunosuppressive drugs inhibit the production of interleukin - 6 and interleukin-8 in cultured cardiac myxoma cells.", RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, (1997 JUL) 97 (1) 60-6., XP000877295 *
ZIERHUT M. ET AL: "[Application of ciclosporin-A eye drops in the treatment of third degree chemical burns]. ANWENDUNG VON CICLOSPORIN-A-AUGENTROPFEN BEI DER BEHANDLUNG VON SCHWEREN VERATZUNGEN.", FORTSCHRITTE DER OPHTHALMOLOGIE, (1987) 84/6 (535-539)., XP000877249 *

Also Published As

Publication number Publication date
WO2000010592A2 (fr) 2000-03-02
GB9818278D0 (en) 1998-10-14
AU1168600A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
EP1293503A4 (fr) Derives de triazole
AU2002225849A1 (en) Distal protection and delivery system and method
AU3549701A (en) Needle protection system
AU5987499A (en) Protect arrangement
AU2001275295A1 (en) Pre-formed honeycomb protector
AU773240C (en) Medicament for treating hypertension
AU3837300A (en) Remedies
AU2001275286A1 (en) Transdermal delivery
ZA977807B (en) New pharmaceutically active compounds.
AU2001286242A1 (en) Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
AU1408300A (en) Hiv infection inhibitors
AU1043201A (en) Cyclosporin formulation
AU5965399A (en) Pharmaceutically active composition
AU4549300A (en) Crash protection device
AU3075200A (en) Telephone and telephone system
AU2335201A (en) Interference suppression in cdma systems
AU2001294782A1 (en) Systems and methods for per use no-answer redial
WO2000010592A3 (fr) Medicaments permettant de prevenir ou de reduire la cicatrisation
CA2414584A1 (fr) 7-hydroepiandrosterone presentant une activite neuroprotectrice
AU4634000A (en) Overvoltage protection
AU2001239314A1 (en) Finger guard
AU5714500A (en) Rolling structure steel
ZA200209632B (en) Methods for prevention of ulcers and improving physiological performance.
WO2004065592A3 (fr) Structure de cristal de proteine
AU2001283331A1 (en) Process and system for providing premium increase protection for insurance policies

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 11686

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase